Product description

ONetakimab – an original humanized monoclonal antibody against IL-17. Approved in Russia for plaque psoriasis. Pending approval for ankylosing spondylitis. BIOCAD will also launch an international Phase III clinical trial with the aim of approval in EU.
Read more

More products from BIOCAD

View all our products (9)

Products from other suppliers